Introduction
Eukaryotic cells are continually challenged by damage to their genomes. As such, DNA repair pathways in mammalian cells are essential for the maintenance of genome integrity, and for countering the induction of tumorigenesis. The repair response to ionizing radiation (IR*) lesions forms one key class of such mechanisms that has been extensively investigated (reviewed in 1-3). The DNA-dependent protein kinase (DNA-PK), consisting of three subunits, is essential to the repair of IR damage. DNA-PK is composed of a heterodimeric DNA binding complex (Ku70 and Ku80 proteins; 4) associated with a protein kinase catalytic sub-unit (DNA-PKcs; 5) on DNA. Ku has a relatively unique property of tightly binding to DNA breaks and other B-form helical deformations without DNA sequence specificity (4) . The binding of Ku to DNA activates DNA-PK (2, 6) .
Mutant cell lines in DNA-PK subunits are observed to be IR sensitive (reviewed in 1-3). Likewise, DNA-PK mutant cells are defective in the joining of DNA breaks during the process of V(D)J recombination (7) (8) (9) (10) . Because V(D)J recombination and IR damage both involve the formation of DNA double-stranded breaks (DSBs), it is likely that these lesions are detected and/or repaired by DNA-PK complexes in a similar manner. Following IR damage, DSBs remain unrepaired in the absence of functional DNA-PK (11) (12) (13) .
An important class of antitumor drugs, etoposides, alter the activity of topoisomerase II in the cell, and induces DNA damage (14) . In vitro, etoposide traps topoisomerase II in an aborted protein-DNA complex, referred to as the cleaved complex. In vivo, incubation with topoisomerase II inhibitors leads to the formation of chromosomal DSBs that are rapidly repaired following removal of the drug (15, 16) . The repair of these DNA products or additional DNA breaks generated from topo II-DNA intermediates, appears to require similar pathways by which IR DNA damage is processed (17) . For example, the IRs Ku80 mutant cells are etoposide hypersensitive and accumulate etoposide-induced DNA lesions (17, 18) . Like IR, etoposide treatment also induces apoptosis (19) .
Here, we have investigated the etoposide sensitivity of cell lines where the three components of DNA-PK are mutated or absent. We find that both Ku70-and Ku80-deficient cells are etoposide hypersensitive. However, mutant cell lines of the catalytic kinase sub-unit, DNA-PKcs, were found to have normal etoposide resistance. Complementation analysis showed that Ku70 or Ku80 addition restores etoposide resistance. We also monitored the complementation of etoposide resistance for a series of site-specific Ku70 mutant genes introduced into the Ku70-deficient cells. Mutations that disrupt the heterodimerization/DNA binding region of Ku70 conferred etoposide sensitivity, supporting the conclusion that the Ku heterodimer must form to promote etoposide damage repair. Furthermore, all three classes of DNA-PK mutant cells show radiation-induced G 2 cell cycle delays demonstrative of normal radiation-induced checkpoints at a time when topoisomerase II is maximally expressed and active. Thus, topoisomerase cleaved complexes may be repaired by a DNA-PK-independent mechanism that involves a Ku heterodimer.
Materials and methods
Cell culture V79-4, sxi-3, sxi3/ϩ Ku80, xrs-6, xrs-6 ϩ Ku80, CHO, ScSV3, SCH8-1 and 8F11-2 cells were propogated in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 5% penicillin-streptomycin and 1 mM L-glutamine (20, 21) . MO59J and MO59K human glioblastoma cell lines were generously donated by Joan Turner and propagated accordingly (22) . Ku70 -/-, Ku70 ϩ/-, Ku70 ϩ/ϩ (J1), and Ku70 -/-derivative murine embryonic stem (ES) cells were maintained as specified (23, 24) .
For preparation of murine embryonic fibroblasts, scid X scid and wildtype (CB-1 X CB-1) mouse matings were conducted and embryos killed at embryonic day 14. Murine embryonic fibroblast (MEF) cultures were prepared by the previously published culture conditions (25) . MEF cultures were used between passages 2 and 5. ScF4 and ScF6 are scid MEF lines, CB1 is a wildtype MEF line from the CB-1 mouse strain.
Etoposide cell survival assays
Exponentially growing cells were plated at 400 cells/well in six-well plates for clonogenic cell survival assays. The following day, the cells were exposed to various concentrations of etoposide VP-16 (Sigma) for 1 h at 37°C in media. Etoposide was freshly diluted from a 5 mM stock solution in DMSO. Cells exposed to etoposide were then washed twice with media ϩ serum, placed in fresh media and incubated for 6-10 days. Plates were stained with crystal violet and colonies counted, as described previously (13) . Colony number per well was compared with parallel untreated wells. All exposures were done in duplicate. The average of two or three experiments was used in the data analysis.
DNA precipitation assay
The level of initial damage formed by etoposide treatment was measured by a previously described procedure (26) . Ku70-deficient, DNA-PK-deficient and control cells were examined in the alkaline lysis methodology to detect the levels of etoposide-mediated strand breaks. Cells were uniformly radiolabeled with [ 14 C]thymidine for 24 h as described (26) . Cells were treated with etoposide as above and immediately lysed to evaluate strand breaks without repair. Percentage of DNA precipitated is calculated from the fraction of precipitated DNA and total radiolabeled DNA. A mean and standard deviation is shown for two experiments.
Measurement of IR-induced G2 delay
Exponentially growing fibroblasts were plated on microscope slides 24 h prior to IR exposure. Cells in G 2 phase were scored by measuring chromosome condensation at 2 or 4 h after IR and colcemid (0.02 µg/ml) treatment. V79, sxi-3, ScSV3, SCH8-1 and 8F11-2 cell lines were treated for 2 h following 300 Rad IR. MEF, murine embryonic fibroblasts (passage 2-5) were treated with colcemid for 4 h following 500 Rad.
Results

Etoposide sensitivity of Ku70-or Ku80-deficient cells
The DNA-dependent protein kinase controls the repair of DNA double-strand breaks accumulated by ionizing radiation damage and by other cytotoxic and DNA break generating agents (reviewed in 1-3). In addition, similar correlations have been made between endonuclease-generated DNA breaks and cytotoxicity of DNA-PK mutant cells (27, 28) .
Although mutant cell lines of the DNA-PKcs and Ku80 subunits have been evaluated in DNA repair (reviewed in 2), Ku70 mutant cell lines have not been available. Recently, KU70 -/-murine ES cells were generated in a gene targeting approach in order to create a Ku70 null mutation (23) . It was observed that the targeted mutation of Ku70 leads to the complete absence of Ku70 protein and promotes ionizing radiation sensitivity, loss of DNA end binding, and V(D)J recombination defects (23) . Furthermore, complementation of these mutant functions can be restored by reintroduction of a wildtype Ku70 cDNA (24) . Without Ku70, Ku80 protein levels are reduced (23) .
In order to study the requirement for Ku and DNA-PK in etoposide-mediated DSB repair, we incubated Ku70 -/-cells, parental cells heterozygous for a Ku70 targeted mutation (Ku70 ϩ/-), and a wildtype Ku70 cDNA complemented derivative in a dose range of etoposide VP16 (0-40 µM) for 1 h at 37°C. Cells were washed free of etoposide and incubated for 1 week in media prior to staining for colony number. We found that Ku70 -/-ES cells were differentially sensitive to this drug compared with the matched controls: parental Ku70 ϩ/-cells and wildtype Ku70 cDNA complemented cells ( Figure 1A ).
To evaluate the DNA damage mediated by etoposide treatment in these cells, we measured the DNA strand breaks formed by the method of Olive (26) . Ku70 -/-and the parental ES cell line, J1, from which the gene targeted Ku70 mutation was derived, were compared. We found that approximately the same fraction of chromatin was in a precipitable fraction following 1 h exposure to etoposide ( Figure 1D ). Therefore, the Ku70-deficient and wildtype matched cells incorporate similar levels of etoposide-meditated DNA damage.
As Ku is likely to function as a heterodimer in eukaryotic 966 cells (2,9,10,23,24,29-32), we asked whether additional Kudeficient cell lines would similarly exhibit etoposide sensitivity. We used two previously characterized Ku80-defective mutants xrs-6 and sxi-3, and their derivatives for this study. Also, cell lines, xrs-6 and sxi-3 complemented with wildtype Ku80 cDNA in a mammalian expression plasmid which restores IR repair capacity, DNA end binding, and V(D)J recombination (20, 30, 33) , were used in parallel. As for Ku70 -/-cells, we observed that Ku80-deficient cells show increased sensitivity to etoposide ( Figure 1B and C). Importantly, etoposide resistance is reconstituted by cells with the introduced Ku80 cDNA to a level equal to the parental cell lines in both cases ( Figure  1B and C). These data support previous findings with another mutant in the XRCC5 group, xrs1, although cDNA complementation analysis was not previously conducted (17) . Therefore, we conclude that Ku is required to effectively combat etoposide damage to mammalian cells. Absence of either subunit of the Ku heterodimer sensitizes cells to etoposide, suggesting that some attribute of either Ku and/or DNA-PK may be necessary regarding pathways of etoposide resistance.
Normal etoposide resistance in DNA-PKcs mutant cell lines
Whereas the general DNA repair and recombination defects observed for Ku and DNA-PK generally correspond to each other, a detailed analysis of the V(D)J recombination mechanism suggests that there are differences in Ku and DNA-PKcs requirements (1, 2, 34, 35) . Functional repair differences between Ku and DNA-PK could be revealed by variations in the types of DNA breaks formed. For example, in V(D)J recombination, only coding junctions are deleteriously affected by the scid mutation (36,37), whereas both coding and signal junctions are impeded in Ku mutants (9, 10, 23) . Mutant cell lines of the XRCC7 complementation group are characterized by an absence of or poorly active DNA-PK. The scid mutant cells in this complementation group are deficient in DNA-PKcs due to an 83 amino acid truncation at the carboxyl terminus of the protein (38, 39) . Likewise, DNA-PKdefective MO59J cells have been derived from a human glioblastoma (22) . MO59J cells have no DNA-PKcs protein or RNA, and DNA-PK activity can be reconstituted in MO59J extracts by addition of purified DNA-PKcs, but not Ku (40) . Murine scid and isogenic wildtype embryonic fibroblast cells lines (scid MEF, ScF4 and ScF6, and wildtype CB1 MEF), were tested as above over the same etoposide dose range (0-20 µM). ScF4, ScF6 and wildtype CB1 had very similar etoposide sensitivity (Figure 2A ). Increased etoposide dose or time of incubation had no differential effects on scid mutant and control cell sensitivities (not shown). Secondly, MO59J (DNA-PKcs-) and MO59K (DNA-PKcsϩ) cells originating from the same tumor were compared for etoposide resistance. We observed that these two cell lines were indistinguishable regarding etoposide resistance and actually the DNA-PKnegative cell line MO59J was slightly more resistant ( Figure  2B ). Another scid cell line, Sc3T3, had the same etoposide sensitivity as Balb 3T3 (not shown) even though these cell lines differ widely in IR sensitivity (21) . In each of these experiments, cell survival at the highest etoposide doses was reduced to 30-40% indicating that increased levels of etoposide would not significantly alter the results.
The DNA precipitation assay was used to determine the level of strand breaks formed by etoposide treatment in DNA-PK mutant and control cells. We found that the MO59J (DNA-PK-) and MO59K (DNA-PKϩ) yielded the same levels of etoposide-mediated strand breaks at two concentrations of etoposide in the range used to determine cell survival. Therefore, these DNA-PK-deficient cells are forming etoposidestimulated breaks and are able to adequately repair them compared with their wildtype cell counterparts. Thus, it appears that Ku and DNA-PKcs deficiencies contribute to different outcomes with regard to the resistance to etoposide damage. Possibly, DNA-PK activity and/or the presence of the kinase is dispensible for this function, whereas loss of Ku activity is not.
Association of Ku etoposide sensitivity region of Ku70 with heterodimerization and DNA binding functions of Ku
Ku stimulates the activity of DNA-dependent protein kinase by association on DNA with the catalytic sub-unit (6) . On the other hand, Ku heterodimers are stable in cells in the absence 967 of DNA-PKcs, and in normal cells much of the Ku is not complexed in DNA-PK (2,40). Ku/DNA-PK readily disassociates in vitro and autophosphorylation of DNA-PK leads to separation of Ku from DNA-PKcs by phosphorylation (6, 41) . Also, the Ku/DNA-PK association can be modulated by other factors with which DNA-PK interacts. Abl tyrosine kinase activity on DNA-PK stimulates removal of DNA-PKcs from DNA and Ku (42, 43) . Each of these mechanisms does not disturb the stability of the Ku heterodimer and does not impact the DNA binding functions of Ku. Thus, there may be DNA-PK-independent functions of Ku in DNA metabolism.
We formed a group of site-specific mutants of Ku70 in order to discriminate structural motifs governing Ku70 functions (24) . The analysis of complementation potential of these mutants in ES Ku70 -/-cells is useful in understanding Ku properties in DNA repair. Ku70 -/-cell lines expressing Ku70 site-specific mutations were established according to (24) . The etoposide sensitivity of complemented Ku70 -/-cell lines was (24) . Etoposide sensitivity assays were conducted as described in Figure 1 and the text. The results of these assays were categorized as ϩ, etoposide resistance, or -, etoposide sensitive. In addition, (-) denotes mutants where the Ku70 gene product is unstable (24) . Residues that are changed in the various mutants are denoted by those residues, then the numerical amino acid position in Ku70, followed by the introduced mutant amino acids. Asterisk (*) refers to an introduced stop codon. The region of Ku80 heterodimerization and DNA end binding is shown bracketed.
then evaluated in cell survival experiments as described above. Mutations in the N-and C-terminus of Ku70 were observed to confer wildtype levels of etoposide resistance compared with the full-length unmutated Ku70 cDNA (Figure 3 ). These N-and C-terminal regions are less well conserved among the Ku homologs than the middle of the gene (24, 32, 44, 45) . Interestingly, we found that etoposide sensitivity was not reconstituted for mutants in a central region of Ku70, corresponding to the domains of the protein governing Ku heterodimerization and DNA end binding functions (24, 32) (Figure 3 ). Within the heterodimerization/DNA end binding domain of Ku70, the mutants that restored etoposide resistance were identical to those that reconstituted IR repair in the other study (24) . Likewise, the etoposide sensitive mutants also failed in repair of IR-induced damage leading to sensitivity.
Similarity between DNA-PK mutants in the performance of ionizing radiation-induced G 2 delay
We evaluated DNA-PK requirements at the stage where topoisomerase II is thought to be important for function, namely the post-replicative G 2 phase and during the process of chromatin condensation (46, 47) . Topoisomerase II is a significant structural protein of the chromosome scaffold (48) . Considering the differential sensitivity to etoposide by DNA-PK mutants, altered G 2 responses to DNA damage generally may be influenced by topoisomerase II. We investigated whether the DNA-PK mutant cells from this study in G 2 phase of the cell cycle may have differing responses to IR damage by an ability to form the well-characterized radiation-induced delays. Recently, it was shown that scid cells demonstrate a decreased fraction of cells entering mitosis following IR treatment (49) .
We used the formation of condensed chromatin as an assay for M phase to determine whether scid, and Ku mutant cell lines have an IR-induced G 2 delay. Asynchronously growing cells at low density on microscope slides were irradiated and treated with colcemid for 2 h prior to staining of the cells to score nuclei with condensed chromatin. Normally, the low percentage of cells in G 2 at the time of irradiation would be expected to prolong G 2 phase, and thus reduce the percentage of cells containing condensed chromatin after 2 h. We found that the Ku-deficient cell line, sxi-3, had the same G 2 delay as parental control cells (V79), as both cell lines showed a 4-to 6-fold decrease in the number of cells with condensed chromatin (Table I) . Also, there were essentially no differences between DNA-PK deficient and control cell lines in this assay. Scid (ScSV3) and human chromosome 8-complemented scid (SCH8-1; DNA-PKϩ) cells each showed radiation-induced G 2 delays. Loss of the human chromosome in SCH8-1 by nonselective outgrowth was used to generate another cell line (8F11-2, DNA-PK-deficient) that also had a comparable level of the IR-induced G 2 delay. Similarly, scid and wildtype MEFs both showed a G 2 delay following IR (Table I) . Therefore, the DNA-PK-deficient cells of this study, whether they are Ku or DNA-PKcs mutants, form an IR-induced G 2 phase delay. Like the activation of radiation-induced G 1 /S checkpoints that have been reported (9,10,50,51), DNA-PK mutant cells in G 2 phase are similarly responsive to other DNA damage signals than the topo II cleaved complex.
Discussion
Several observations make it likely that the Ku heterodimer rather than DNA-PK, or individual DNA-PK subunits are relevant regarding etoposide sensitivity. It is intriguing that Ku-deficient cells are sensitive to the toxic effects of etoposide VP16, whereas DNA-PKcs-deficient cell lines are not ( Figures  1 and 2) . The Ku70-and Ku80-deficient cell lines had similar hypersensitivities to etoposide relative to control cells where Ku70 or Ku80 genes were reintroduced by transfection. In the case of Ku70 -/-ES cells that are genetically better defined, restoration of the Ku70 cDNA is sufficient to completely reconstitute etoposide resistance relative to the Ku70 ϩ/-background ( Figure 1A) . Also, compared with wildtype control cells, the Ku70 -/-ES cells acquire the same levels of etoposide damage in the exposure time, arguing that initial damage levels between the cells are not significantly different ( Figure 1D ). There is currently no explanation for differences between xrs6 and sxi-3 cells regarding etoposide sensitivity, however, it should be noted that these cell lines also differ in IR sensitivity and V(D)J recombination in the same way (20, 30) , so that additional factors may contribute to the absolute levels of etoposide repair as they do to the other functions. Nevertheless, within the same cell line, Ku deficiency of either sub-unit leads to greater etoposide sensitivity.
969
Although properties attributable to one sub-unit of the Ku heterodimer are possible, Ku generally appears to function as a heterodimer. Studies with gene targeted deletion of Ku80 and Ku70, indicates that Ku70 and Ku80 levels are dependent on the stable production of the other protein in the heterodimer (9, 10, 23) . Also, in vitro Ku DNA end binding is determined by both subunits together, as either Ku70 or Ku80 has no DNA end binding capacity alone (32, 52) . Importantly, we have shown here by an extensive Ku70 mutational analysis, that only mutants retaining heterodimerization and DNA binding properties of Ku restore the capacity for resistance to etoposideinduced cytotoxicity (Figure 3) . No specific epitopes of Ku70 were discovered in this analysis that particularly sensitized complemented cells to etoposide and not to other types of damage. Considering that Ku and DNA-PKcs may have separable functions in other contexts such as V(D)J recombination, searching for Ku70 mutations differentially affecting DNA-PK activity would be of most interest in the future. It is unlikely that further mutagenesis of the heterodimerization/ DNA binding region will lead to the identification of epitopes separating etoposide and IR repair as both appear to require these properties of Ku.
DNA-PK mutants from two sources (murine scid and human MO59J) cells were found to have etoposide resistance in the normal range (Figure 2A and B) . We showed that strand breaks stimulated by etoposide occurred equally comparing MO59J and the DNA-PKϩ MO59K cells ( Figure 2C ). Considering a different outcome found for three Ku mutants, it appears that DNA-PKcs deficiencies do not effect the etoposide resistance pathway. An alternative explanation for these data might be that a low level of DNA-PK activity produced by the mutant activity of the scid DNA-PK protein is adequate for a function in etoposide resistance. Although this hypothesis cannot be completely ruled out by available data, several observations make it a less likely alternative. The scid mutation defects in other respects (DNA-PK activity, IR double-strand break repair, and V(D)J recombination coding joint formation) are quite severe (2, 3) . In addition, MO59J cells have no detectable DNA-PKcs RNA, protein or enzyme activity (40) . Leakiness due to the scid phenotype would have to specifically effect this repair pathway and not others.
Several observations are consistent with the notion that Ku can operate independently of DNA-PK in mammalian cells. There is quantitatively more Ku than DNA-PKcs in mammalian cells, and most Ku does not appear to be tightly associated with DNA-PK (2). The Ku DNA helicase (53) and DNA binding activities do not require an involvement in DNA-PK (2). A DNA-PK activity independent of Ku has recently been demonstrated biochemically (54) . Furthermore, mutation of Ku diminishes both signal and coding joints of V(D)J recombination, whereas mutation of DNA-PKcs only destroys coding joint formation (reviewed in 2,3,34). The signal DNA ends that are V(D)J recombination intermediates are likely to be unique structures for repair, and includes the possibility of protein-DNA complexes (55) . For example, Rag1 and Rag2 proteins that initiate the cleavages of V(D)J recombination have been observed to remain associated with signal DNA ends (56) . In this regard, signal ends and topoisomerase IIcleaved complexes may both have protein-associated structures.
Saccharomyces cerevisiae contains a Ku heterodimer that functions in DNA repair pathways independently of homologous recombination (31, 57, 58) . As in mammalian cells, yeast Ku requires both subunits as a heterodimer (31) . To date, there is no evidence that yeast cells have a DNA-dependent protein kinase, as no homolog to DNA-PKcs has been discovered from the complete genome database, and no DNA-dependent protein kinase biochemical activity has been reported, unlike for other eukaryotes (K.Shannon and D.Weaver, unpublished observations).
Ku-deficient yeast accumulate in G 2 as if there is a critical function for Ku during DNA replication or in G 2 (44, 59) . Topoisomerase II mutants at the non-permissive temperature also accumulate in G 2 , but after completion of DNA synthesis (46) . Also in yeast, Ku-deficient cells are defective in telomere length maintenance (58, 60) . Because telomere replication occurs following the bulk of DNA synthesis, a telomere shortening defect may reflect an inability to resolve topoisomerase/Ku-mediated repair steps. The DNA-PK-independent functions of Ku in yeast may be directly related to similar properties in mammalian cells.
It is interesting that topoisomerase II is a phosphoprotein with maximum activity in G 2 (61) , consistent with our observations for the cell cycle distribution of DNA-PK activity (S.Inoue and D.Weaver, in preparation). Topoisomerase II is known to be an in vitro substrate for DNA-PK (62), but there is no in vivo demonstration of co-association of these proteins. On the other hand, topoisomerase II removal of torsional stress could be regulated in mechanisms where Ku is specifically acting in parallel. For example, it is known that topoisomerase IIa is associated with new DNA synthesis (63) . Possibly, there is a redundant function between Ku and topoisomerase II in the cell cycle such that the absence of both activities would be lethal. This property is not likely to be DSB repair or Kudependent transcription, because it appears that there is a requirement for DNA-PK complexes, rather than just Ku (2, 64 ). An alternative might be that Ku identifies chromatin regions for topoisomerase II action, where lack of Ku may alter the normal accessibility of topoisomerase II to sites for DNA repair and/or completion of DNA synthesis. However, Ku-deficient and control cells yield the same levels of etoposide-mediated initial damage ( Figure 1D ) indicative of equivalent accessibility of topoisomerase II.
Topoisomerase II is also complex in its functions in G 2 phase of the cell cycle. In addition to cell cycle arrest mediated through checkpoint pathways similar to other forms of DNA damage, topoisomerase II inhibitors can also contribute to other forms of cell cycle delays. A topoisomerase II-dependent G 2 checkpoint was discovered that senses DNA catenation (65) , as demonstrated by the analysis of bisdioxopiperazines which specifically block topoisomerase II activity without creating strand breaks (66) . Since etoposides are inhibiting topoisomerase II as well as creating strand breaks, the direct effects of etoposide on these two independent G 2 checkpoint mechanisms are hard to discriminate.
If etoposide effects monitored by DNA-PK deficiencies are due to strand breaks generated it may be that Ku, but not DNA-PK, is directly involved in the repair of topoisomerase cleaved complex breaks in the cell. Possibly Ku would work in concert with other repair factors independently of DNAPKcs. If the process being interrupted by etoposide is the inhibited topoisomerase complex engaged in the relief of supercoils following DNA replication, strong candidate proteins for these functions may be other replication factors involved in DNA synthesis and/or recombination. To date, Ku has been associated in complexes also containing the strand 970 exchange proteins, DNA polymerases, processivity factors, and DNA binding proteins: Rad51, DNA polymerase episilon, Replication Factor C, and Replication Protein A (67) .
